--SIGA is a debt-free company sitting on $150M in cash.
--SIGA's TPOXX and Monkeypox
SIGA distributes TPOXX, an anti-viral treatment for human smallpox caused by variola virus. Variola virus is a family of virus, similar to coronavirus being a family of virus that causes Covid, SARS, and the common cold. Monkeypox belongs to the variola virus family and is thus a target for TPOXX.
From a price-to-earnings perspective, too, SIGA is underpriced. The average pharmaceutical stock has a PE of 22x, while SIGA trades at a little over 12x:
--SIGA's TPOXX and Monkeypox
SIGA distributes TPOXX, an anti-viral treatment for human smallpox caused by variola virus. Variola virus is a family of virus, similar to coronavirus being a family of virus that causes Covid, SARS, and the common cold. Monkeypox belongs to the variola virus family and is thus a target for TPOXX.
From a price-to-earnings perspective, too, SIGA is underpriced. The average pharmaceutical stock has a PE of 22x, while SIGA trades at a little over 12x:

